[Peroral antithrombotic treatment]

Ugeskr Laeger. 2006 Jan 9;168(2):203; author reply 203-4.
[Article in Danish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Antifibrinolytic Agents / administration & dosage*
  • Antifibrinolytic Agents / adverse effects
  • Aspirin / administration & dosage
  • Aspirin / adverse effects
  • Dipyridamole / administration & dosage
  • Dipyridamole / adverse effects
  • Drug Therapy, Combination
  • Humans
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Stroke / prevention & control
  • Vitamin K / antagonists & inhibitors

Substances

  • Antifibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Vitamin K
  • Dipyridamole
  • Aspirin